Wednesday, November 3, 2021

Cipla unit gets notice from US firm for termination of acquisition deal

Cipla unit gets notice from US firm for termination of acquisition deal In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million (around Rs 1,560 crore).

from Moneycontrol Business News https://ift.tt/3BMCi0g
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Apollo Micro Systems shares surge 15% following Rs 25 cr order wins from DRDO, other defence PSUs

Apollo Micro Systems shares saw a significant rise. The company secured orders worth Rs 25.12 crores from DRDO and Defence PSUs. This news b...